PDL BIOPHARMA INC filings

SEC filings by PDL BIOPHARMA INC (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13G/A2024-02-09DIMENSIONAL FUND ADVISORS LPPDL BIOPHARMA, INC.7,392,6566.5%EDGAR
SC 13G/A2023-02-10DIMENSIONAL FUND ADVISORS LPPDL BIOPHARMA, INC.7,426,5036.5%EDGAR
SC 13G/A2022-02-08DIMENSIONAL FUND ADVISORS LPPDL BIOPHARMA, INC.7,458,8936.5%EDGAR
SC 13G/A2021-02-12DIMENSIONAL FUND ADVISORS LPPDL BIOPHARMA, INC.7,667,5976.7%EDGAR
SC 13G/A2021-02-11RENAISSANCE TECHNOLOGIES LLCPDL BIOPHARMA, INC.00.0%EDGAR
SC 13G/A2021-02-11BRANDES INVESTMENT PARTNERS, LPPDL BIOPHARMA, INC.7,046,7016.2%EDGAR
SC 13D2021-01-11Silver Point Capital L.P.PDL BIOPHARMA, INC.--EDGAR
SC 13G/A2021-01-11Park West Asset Management LLCPDL BIOPHARMA, INC.14,397,21212.6%EDGAR
SC 13G2020-12-16Silver Point Capital L.P.PDL BIOPHARMA, INC.13,513,46011.8%EDGAR
SC 13G/A2020-08-28Park West Asset Management LLCPDL BIOPHARMA, INC.6,717,2595.9%EDGAR
SC 13G2020-08-28Park West Asset Management LLCPDL BIOPHARMA, INC.5,793,4975.1%EDGAR
SC 13D/A2020-05-26PDL BIOPHARMA, INC.Evofem Biosciences, Inc.3,333,3346.3%EDGAR
SC 13D/A2020-03-10ENGINE CAPITAL, L.P.PDL BIOPHARMA, INC.2,563,8542.2%EDGAR
SC 13D/A2020-02-28ENGINE CAPITAL, L.P.PDL BIOPHARMA, INC.3,969,4213.5%EDGAR
SC 13G/A2020-02-13RENAISSANCE TECHNOLOGIES LLCPDL BIOPHARMA, INC.8,170,6317.2%EDGAR
SC 13G/A2020-02-12VANGUARD GROUP INCPDL BIOPHARMA, INC.5,523,9524.8%EDGAR
SC 13G/A2020-02-12DIMENSIONAL FUND ADVISORS LPPDL BIOPHARMA, INC.9,530,9498.4%EDGAR
SC 13G/A2020-02-05BlackRock Inc.PDL BIOPHARMA, INC.10,775,0029.4%EDGAR
SC 13G2020-01-09BRANDES INVESTMENT PARTNERS, LPPDL BIOPHARMA, INC.5,811,0805.1%EDGAR
SC 13D2019-10-23ENGINE CAPITAL, L.P.PDL BIOPHARMA, INC.3,827,4593.4%EDGAR